{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 122,
        "end": 126
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 34,
        "end": 42
      }
    },
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 92,
        "end": 118
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 122,
        "end": 131
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "27378608_9",
  "text": "Our study provides evidence for a FcyRIIIa V allele-restricted pCR benefit from neoadjuvant trastuzumab plus lapatinib in HER2 + BC .The Pharmacogenomics Journal advance online publication , 5 July 2016 ; doi :10.1038 / tpj .2016.51 ."
}
